Literature DB >> 3915257

Characterization of an insulin degrading enzyme from cultured human lymphocytes.

R A Roth, M L Mesirow, D J Cassell, K Yokono, S Baba.   

Abstract

An insulin degrading enzyme from cultured human lymphocytes, IM-9 cells, has been purified and characterized. The biochemical, enzymatic and immunological characteristics of this enzyme were all found to be similar to the characteristics of insulin degrading enzymes previously isolated from rat and pig skeletal muscle. Furthermore, this insulin degrading enzyme was found to have no effect on the structure of the insulin receptor nor to be linked to the insulin receptor either on the plasma membrane of cells or when they are shed into the media. The present studies suggest that the IM-9 lymphocytes, which have been extensively used to study the human insulin receptor, may also be a good system for studying human insulin degrading enzymes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3915257     DOI: 10.1016/s0168-8227(85)80026-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Limitations of capillary plasma immunoreactive insulin assay as an epidemiological tool.

Authors:  D Simmons; H Dhar; T D Hockaday
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

2.  Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease.

Authors:  K Shii; R A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.

Authors:  Sathish Kumar; Sandesh Singh; Désirée Hinze; Michaele Josten; Hans-Georg Sahl; Martin Siepmann; Jochen Walter
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

4.  Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).

Authors:  J P Bai; M J Hsu; W T Shier
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

5.  Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.

Authors:  Erik Portelius; Niklas Mattsson; Josef Pannee; Henrik Zetterberg; Magnus Gisslén; Hugo Vanderstichele; Eleni Gkanatsiou; Gabriela A N Crespi; Michael W Parker; Luke A Miles; Johan Gobom; Kaj Blennow
Journal:  Mol Neurodegener       Date:  2017-02-20       Impact factor: 14.195

6.  An insulin epidermal growth factor-binding protein from Drosophila has insulin-degrading activity.

Authors:  J V Garcia; M P Stoppelli; S J Decker; M R Rosner
Journal:  J Cell Biol       Date:  1989-01       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.